Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV
Clinical trial NCT00362336 · COMPLETED
Trial details
- NCT number
- NCT00362336
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2008-05-01
- Enrollment
- 622
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.